TABLE 2.
Recombination substrates containing a mutated rrnA fragmenta
| Vector | rrnA positionb | Antibiotic | Reference |
|---|---|---|---|
| pMV361ΔKan-Gm-rRNA | A2059C | Clarithromycin | 40 |
| pMV361ΔKan-Gm-rRNA | A2059G | Clarithromycin | 40 |
| pMV361ΔKan-Gm-rRNA | A2058C | Clarithromycin | 40 |
| pMV361ΔKan-Gm-rRNA | A2058G | Clarithromycin | 40 |
| pMV361ΔKan-Gm-rRNA | G1491A | Paromomycin | 39 |
| pMV361ΔKan-Gm-rRNA | G1491C | Paromomycin | 39 |
| pMV361ΔKan-Gm-rRNA | G1491T | Paromomycin | 39 |
All vectors harbor a mutated rrnA fragment, which confers antibiotic resistance (the antibiotic is shown in the middle column) upon recombination with the chromosomal wild-type rrnA gene.
The rrnA position of the mutated nucleotide.